A late-stage study of Johnson & Johnson's Covid-19 vaccine candidate has been paused while the company investigates whether a study participant's "unexplained illness" is related to the shot.The company said in a statement on Monday...
Full ArticleCovid 19 coronavirus: Second vaccine trial paused over 'unexplained illness'
New Zealand Herald
0 shares
1 views
You might like
Related news coverage
Group calls for end to 'cozy' and 'unacceptable' relationship between senior government officials and Facebook
National Post
OTTAWA – A broadcasting advocacy group is urging the federal Heritage minister to put an end to the seemingly “cozy” and..
-
Second wave will be 'weeks and months' of limiting contacts, but Trudeau says 'blunt' lockdowns unnecessary
National Post
-
NA Proactive news snapshot: CleanSpark, XPhyto Therapeutics, GGX Gold, Altamira Gold, Goldseek Resources, Mawson Gold, UPDATE …
Proactive Investors
-
NA Proactive news snapshot: CleanSpark, Newrange Gold, XPhyto Therapeutics, GGX Gold, Altamira Gold, Goldseek Resources UPDATE …
Proactive Investors
-
NA Proactive news snapshot: XPhyto Therapeutics, GGX Gold, Altamira Gold, Goldseek Resources, Mawson Gold, Innocan Pharma UPDATE…
Proactive Investors
Advertisement
More coverage
Dangers Of Jumping The Gun On A COVID-19 Vaccine – Analysis
Eurasia Review
By Hannah Clapham*
With COVID-19 cases still rising globally, the race is on for a vaccine. Pressures are mounting to..
-
NA Proactive news snapshot: Mawson Gold, Innocan Pharma, District Metals, XPhyto Therapeutics …
Proactive Investors
-
Pfizer's late-stage coronavirus vaccine trial is near complete enrollment with 42,000 volunteers
Upworthy
-
AstraZeneca resuming US testing of COVID-19 vaccine
SeattlePI.com
-
Johnson Johnson pauses coronavirus vaccine trial after participant contracts "unexplained illness"
NaturalNews.com